4.6 Article

Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2

Helen Hanson et al.

Summary: This paper presents a summary of the process and key recommendations from a national consensus on the clinical management of BRIP1, PALB2, RAD51D, and RAD51C carriers.

JOURNAL OF MEDICAL GENETICS (2023)

Review Genetics & Heredity

Prioritizing the detection of rare pathogenic variants in population screening

Paul Lacaze et al.

Summary: Population genomic screening for detecting carriers of rare monogenic variants with medically actionable conditions is well-supported by evidence of clinical utility and cost effectiveness. However, less evidence supports the use of polygenic risk scores in screening, as they do not detect rare variants. Relying solely on polygenic scores for population screening without considering the detection of high-risk rare monogenic variants is not recommended, as cautioned by Lacaze et al.

NATURE REVIEWS GENETICS (2023)

Editorial Material Obstetrics & Gynecology

Population-based genetic testing for cancer susceptibility genes: quo vadis?

Ranjit Manchanda et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Review Oncology

Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis

Faiza Gaba et al.

Summary: Women with BRCA1 or BRCA2 gene mutations undergo operations to remove their ovaries in order to prevent ovarian cancer. This study found that the operation was not linked with a reduced risk of developing breast cancer when considering both BRCA1 and BRCA2 carriers together. However, it was linked with a reduced risk of breast cancer when considering only BRCA2 carriers. Additionally, the operation was associated with increased survival following breast cancer in BRCA1 and BRCA2 carriers.

CANCERS (2023)

Article Surgery

Patient-reported outcomes post prophylactic risk-reducing mastectomy: improved breast and psychosocial satisfaction yet poorer physical well-being

Kristy Mansour et al.

Summary: This study investigated patient-reported outcomes for patients with high breast cancer risk undergoing risk reduction mastectomy and reconstruction. The results showed higher breast and psychosocial satisfaction, but lower scores for chest, abdomen, and sexual well-being. The use of DIEP flap reconstruction resulted in higher quality of life outcomes compared to breast implant reconstruction.

ANZ JOURNAL OF SURGERY (2023)

Article Oncology

Patient reported outcomes after risk-reducing surgery in patients at increased risk of ovarian cancer

L. Philp et al.

Summary: Women at an increased risk of ovarian cancer undergoing risk-reducing bilateral salpingo-oophorectomy (RRBSO) reported decreased health-related worry and tension post-operatively, but also experienced lower levels of health and quality of life, decreased interest in sex, and feeling less physically attractive. Compared to patients with ovarian neoplasms, at-risk patients had lower levels of disease-related life interference and treatment burden, less worry, and better overall health.

GYNECOLOGIC ONCOLOGY (2022)

Article Surgery

Patient reported outcome measures in a cohort of patients at high risk of breast cancer treated by bilateral risk reducing mastectomy and breast reconstruction

A. Gandhi et al.

Summary: This study investigated the patient reported outcomes of women undergoing bilateral risk reducing mastectomies (BRRM) and breast reconstruction. The findings showed high levels of patient satisfaction with the surgery, but a cancer diagnosis had a negative impact on quality of life outcomes and higher preoperative anxiety levels affected postoperative psychosocial well-being.

JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2022)

Article Surgery

Patient-reported outcomes following bilateral prophylactic mastectomy and immediate breast reconstruction: comparing implant-based with autologous breast reconstruction

Renee M. L. Misere et al.

Summary: This study compared the long-term quality of life between immediate implant-based breast reconstruction (IBBR) and autologous breast reconstruction (ABR) in women who underwent bilateral prophylactic mastectomy (BPM). The results suggest that women who underwent immediate ABR had higher satisfaction with their breasts and better physical well-being compared to those who underwent immediate IBBR after BPM.

EUROPEAN JOURNAL OF PLASTIC SURGERY (2022)

Article Genetics & Heredity

Satisfaction and Quality of Life of Healthy and Unilateral Diseased BRCA1/2 Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire

Natalie Herold et al.

Summary: This study assessed satisfaction and health-related quality of life after bilateral risk-reducing mastectomy and reconstruction. The results showed that satisfaction and quality of life were dependent on the time of surgery rather than the surgical technique or type of reconstruction. Previvors had higher satisfaction scores in psychosocial, sexual, and physical well-being compared to survivors.

GENES (2022)

Article Oncology

The impact of bilateral salpingo-oophorectomy on sexuality and quality of life in women with breast cancer

Paige E. Tucker et al.

Summary: The study found that whether breast cancer survivors had undergone bilateral salpingo-oophorectomy did not significantly impact their sexual function and quality of life, with similar scores reported in both groups.

SUPPORTIVE CARE IN CANCER (2021)

Article Obstetrics & Gynecology

Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study

F. Gaba et al.

Summary: The study found high acceptability of risk-reducing early salpingectomy and delayed oophorectomy (RRESDO) among premenopausal women at increased ovarian cancer risk, particularly those concerned about sexual dysfunction. While satisfaction rates with risk-reducing salpingo-oophorectomy (RRSO) remained high, regret rates were higher for premenopausal women compared to postmenopausal women. The use of hormone replacement therapy (HRT) following premenopausal RRSO did not increase satisfaction levels but did reduce symptoms of vaginal dryness.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)

Article Oncology

Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial

Faiza Gaba et al.

Summary: Risk-reducing early salpingectomy is proposed as a two-step surgical alternative for pre-menopausal women declining or delaying oophorectomy, with the primary objective being to evaluate its impact on sexual function.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

Review Oncology

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021

Mary B. Daly et al.

Summary: The NCCN Guidelines focus on assessing genetic variants associated with increased risk of breast, ovarian, and pancreatic cancer, particularly BRCA-related breast/ovarian cancer syndrome and Li-Fraumeni syndrome. Individuals with pathogenic BRCA1/2 variants have high risks of breast and ovarian cancer, as well as elevated risks of prostate cancer and pancreatic cancer. Li-Fraumeni syndrome is associated with high lifetime risks of various cancers.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Article Medicine, General & Internal

A Population-Based Study of Genes Previously Implicated in Breast Cancer

Chunling Hu et al.

Summary: This study provides population-based estimates of the prevalence and risk of breast cancer associated with pathogenic variants in known cancer-predisposition genes. The results highlight the varying levels of risk associated with different genes, such as high risk for BRCA1 and BRCA2 and moderate risk for PALB2, as well as associations with specific subtypes of breast cancer for genes like RAD51C and RAD51D.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women

Leila Dorling et al.

Summary: This study sequenced samples from 60,466 women with breast cancer and 53,461 controls using a panel of 34 putative susceptibility genes, identifying associations between protein-truncating variants in certain genes and breast cancer risk. The results provide important information for genetic counseling and define genes that are most clinically useful for predicting breast cancer risk.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Genetics & Heredity

Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors

Andrew Lee et al.

Summary: The study developed a multifactorial risk model for epithelial tubo-ovarian cancer in women of European ancestry, which can help identify high-risk individuals and provide assistance for targeted screening and prevention.

JOURNAL OF MEDICAL GENETICS (2021)

Article Surgery

Effect of risk-reducing salpingo-oophorectomy on the quality of life in Korean BRCA mutation carriers

Sumin Chae et al.

Summary: This study found no significant differences in mental QOL, psychosocial status, sexual function, and menopausal symptoms between the RRSO and non-RRSO groups among BRCA mutation carriers. RRSO uptake only had a negative impact on physical QOL.

ASIAN JOURNAL OF SURGERY (2021)

Article Medicine, General & Internal

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Usha Menon et al.

Summary: The long-term follow-up of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) did not show a significant reduction in deaths due to ovarian or tubal cancer with screening. While there was an increase in early-stage cancer detection in the MMS group, it did not translate into lives saved, highlighting the importance of specifying cancer mortality as the primary outcome in screening trials. Consequently, general population screening for ovarian and tubal cancer cannot be recommended.

LANCET (2021)

Article Medicine, General & Internal

Quality of Life After Bilateral Risk-Reducing Mastectomy and Simultaneous Reconstruction Using Pre-Pectoral Silicone Implants

Nick Spindler et al.

Summary: Research indicates that bilateral risk-reducing mastectomy with simultaneous breast reconstruction surgery leads to a health-related quality of life similar to that of the general population. While the surgery may have significant effects on psychological, physical, and social aspects, immediate breast reconstruction can preserve the appearance and boost the patient's self-esteem.

PATIENT PREFERENCE AND ADHERENCE (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Oncology

Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score

Chi Gao et al.

Summary: This study evaluated the joint association of pathogenic variants in breast cancer predisposition genes and polygenic risk scores with breast cancer in the general population. The findings suggest that polygenic risk scores facilitate personalized breast cancer risk assessment among carriers of pathogenic variants in predisposition genes.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers A Nonrandomized Controlled Trial

Miranda P. Steenbeek et al.

Summary: This study shows that women with BRCA1/2 pathogenic variants have better menopause-related quality of life after risk-reducing salpingectomy (RRS) compared to risk-reducing salpingo-oophorectomy (RRSO), regardless of hormone replacement therapy. Results suggest that RRS may be a preferable option for delaying the onset of menopause.

JAMA ONCOLOGY (2021)

Article Oncology

Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study

Dhivya Chandrasekaran et al.

Summary: Multigene testing in ovarian cancer, especially after counselling by multidisciplinary clinical teams, shows a high uptake rate of 97% and identifies a significant proportion of patients with pathogenic variants such as BRCA1/BRCA2, RAD51C/RAD51D/BRIP1. Prospective parallel somatic and germline panel testing is recommended to maximize variant identification in cancer patients.

CANCERS (2021)

Review Surgery

Bilateral risk-reducing mastectomy - surgical procedure, complications and financial benefits

Piotr Gierej et al.

Summary: Risk-reducing mastectomy is a recognized prophylactic treatment for women at high and very high risk of breast cancer development, with simultaneous reconstruction using implants or free tissue flaps being common methods, which may require corrective reoperations postoperatively.

POLISH JOURNAL OF SURGERY (2021)

Article Oncology

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels

Emma J. Crosbie et al.

Summary: RRBSO is highly effective in reducing the risk of high-grade serous ovarian cancer and primary peritoneal cancer in individuals with BRCA1/2 pathogenic variants, although it does not completely eliminate the risk. Detailed screening and treatment in specialist centers may have an impact on the risk reduction effect post-surgery.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Obstetrics & Gynecology

Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes

R. Manchanda et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)

Review Obstetrics & Gynecology

Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers

Faiza Gaba et al.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2020)

Article Oncology

Population-based Genetic Testing for Precision Prevention

Olivia Evans et al.

CANCER PREVENTION RESEARCH (2020)

Editorial Material Obstetrics & Gynecology

Risk-reducing early salpingectomy and delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in women at increased risk: a commentary

F. Gaba et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2019)

Review Oncology

Update on Genetic Testing in Gynecologic Cancer

Susan M. Domchek et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Article Environmental Sciences

The Effect of Prophylactic Adnexectomy on the Quality of Life and Psychosocial Functioning of Women with the BRCA1/BRCA2 Mutations

Marta Stanisz et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)

Review Oncology

BRCA Mutations and Breast Cancer Prevention

Joanne Kotsopoulos

CANCERS (2018)

Article Medicine, General & Internal

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Karoline B. Kuchenbaecker et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Multidisciplinary Sciences

High grade serous ovarian carcinomas originate in the fallopian tube

S. Intidhar Labidi-Galy et al.

NATURE COMMUNICATIONS (2017)

Article Pediatrics

Tools for 'safety netting' in common paediatric illnesses: a systematic review in emergency care

Evelien de Vos-Kerkhof et al.

ARCHIVES OF DISEASE IN CHILDHOOD (2016)

Article Oncology

Cancer incidence and mortality projections in the UK until 2035

C. R. Smittenaar et al.

BRITISH JOURNAL OF CANCER (2016)

Review Obstetrics & Gynecology

The role of the fallopian tube in the origin of ovarian cancer

Britt K. Erickson et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)

Editorial Material Medicine, General & Internal

GUIDELINES Familial breast cancer: summary of updated NICE guidance

D. Gareth Evans et al.

BMJ-BRITISH MEDICAL JOURNAL (2013)

Article Obstetrics & Gynecology

Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis

R. Manchanda et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2012)

Article Obstetrics & Gynecology

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status

R. Manchanda et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2011)

Article Oncology

Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers

Victor R. Grann et al.

BREAST CANCER RESEARCH AND TREATMENT (2011)

Article Oncology

Breast cancer-related preferences among women with and without BRCA mutations

Victor R. Grann et al.

BREAST CANCER RESEARCH AND TREATMENT (2010)

Article Health Care Sciences & Services

Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?

Donna Rowen et al.

HEALTH AND QUALITY OF LIFE OUTCOMES (2009)

Article Oncology

Quality of life after bilateral prophylactic mastectomy

Ann M. Geiger et al.

ANNALS OF SURGICAL ONCOLOGY (2007)